Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +4.64% |
|
+5.33% | -16.84% |
Jun. 06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.84% | 128M | |
+60.25% | 841B | |
+39.32% | 625B | |
-4.49% | 360B | |
+18.30% | 327B | |
+9.64% | 300B | |
+15.54% | 242B | |
+4.09% | 228B | |
+18.51% | 227B | |
+12.87% | 174B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- HC Wainwright Adjusts I-Mab's Price Target to $70 From $80, Keeps Buy Rating